Evidence map›Paper›PMID 36838212›Full record

ArticleMicroorganisms2023

Uptake of

Tingyu Yin, Xiaoxi Zhang, Shun Iwatani, Kazuhiko Miyanaga, Naoyuki Yamamoto

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Immunomodulatory effects of probioticFrontiers in microbiology · 2025
    Article
  2. Review
  3. GroEL Secreted fromMicroorganisms · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Tingyu YinSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama 226-8501, Kanagawa, Japan.ORCID 0000-0001-5170-3636
Xiaoxi ZhangDepartment of Microbiology and Immunology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan.
Shun IwataniSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama 226-8501, Kanagawa, Japan.
Kazuhiko MiyanagaDepartment of Infection and Immunity, School of Medicine, Jichi Medical University, 3311-1, Yakushiji, Shimotsuke-shi 329-0498, Tochigi, Japan.
Naoyuki YamamotoSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama 226-8501, Kanagawa, Japan.ORCID 0000-0001-6546-1404
Tokyo Institute of Technology · JPJichi Medical University · JPKeio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several probiotic lactic acid bacteria (LAB) exert immunomodulatory effects on the host. However, the reasons for the different effects of LAB have not been fully elucidated. To understand the different immunomodulatory effects of LAB, we evaluated the levels of critical molecules in differentiated monocytic THP-1 and dendritic cells (DCs) following the uptake of various LAB strains.

Indexed as

CAP-1dendritic cellsIL-12lactic acid bacteriaLevilactobacillus brevisSlpBTHP-1

Identifiers

PMID36838212
PMCPMC9962577
OpenAlexW4317508182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.